Heavy alcohol use reduces the levels of the brain-derived neurotrophic factor (BDNF) in the prefrontal cortex of rodents through the upregulation of microRNAs targeting BDNF mRNA. In humans, an inverse correlation exists between circulating blood levels of BDNF and the severity of psychiatric disorders including alcohol abuse. Here, we set out to determine whether a history of heavy alcohol use produces comparable alterations in the blood of rats. We used an intermittent access to 20% alcohol using the 2-bottle choice paradigm (IA20%2BC), and measured circulating levels of BDNF protein and microRNAs in the serum of Long-Evans rats before and after 8-weeks of excessive alcohol intake. We observed that the drinking profile of heavy alcohol users is not unified; Whereas 70% of the rats gradually escalate their alcohol intake (Late Onset), 30% of alcohol users exhibit a very Rapid Onset of drinking (Rapid Onset). We found that serum BDNF levels are negatively correlated with alcohol intake in both Rapid Onset and Late Onset rats. In contrast, increased expression of the microRNAs (miRs) targeting BDNF, miR30a-5p, miR-195-5p, miR191-5p and miR206-3p, was detected only in the Rapid Onset rats. Finally, we report that the alcohol-dependent molecular changes are not due to alterations in platelet number. Our data suggest that rats exhibit both Late and Rapid Onset of alcohol intake. We further show that heavy alcohol use produces comparable changes in BDNF protein levels in both groups. However, circulating microRNAs are responsive to alcohol only in the Rapid Onset rats.
Introduction
Alcohol use disorder (AUD) is a detrimental health concern that affects 15% of the population in the US (Grant et al., 2015; WHO, 2014) . Although the majority of people consume alcohol throughout their lifetime, only a small subset of them develop AUD. This conundrum suggests the existence of endogenous factors that protect the majority of the population from developing alcohol addiction.
One such endogenous protective factor is the brain derived neurotrophic factor (BDNF).
BDNF belongs to the nerve growth factor (NGF) family of neurotrophic factors (Bothwell, 2014) which signals through tropomyosin-related kinase B (TrkB) receptor (Minichiello, 2009) . BDNF binding to TrkB results in the activation of the mitogen activated protein kinase (MAPK)/extracellular signal regulated kinases 1 and 2 (ERK1/2), phospholipase C gamma (PLC gamma), and phosphoinositol 3-kinase (PI3K) pathways, and to the initiation of transcriptional and translational machineries (Huang and Reichardt, 2003; Leal et al., 2014; Ruiz et al., 2014) .
The BDNF/TrkB pathway plays an important role in central nervous system (CNS) development including neuronal differentiation and synapse formation (Park and Poo, 2013) . In the adult brain, BDNF/TrkB signaling participates in synaptic and structural plasticity (Minichiello, 2009; Panja and Bramham, 2014) , as well as learning and memory (Bekinschtein et al., 2014) . In contrast, binding of BDNF or its immature proBDNF form to the low affinity p75 Neurotrophin receptor (p75NTR) activates a different set of targets including c-Jun amino terminal kinase (JNK), RhoA and nuclear factor kappa-light-chain-enhancer of activated B cells (NFkB) (Kraemer et al., 2014b) , that in turn reduce spine complexity and density (Zagrebelsky et al., 2005) , induce apoptosis (Kraemer et al., 2014a; Teng et al., 2005) , and facilitate long term depression (Woo et al., 2005) .
Over more than a decade, we and others observed that the BDNF system interacts with alcohol in a unique way (Logrip et al., 2015; Ron and Berger, 2018) . We found that moderate but not excessive intake of alcohol increases the expression of BDNF in the dorsal striatum and more specifically in the dorsolateral striatum (DLS) of rodents (Jeanblanc et al., 2009; Logrip et al., 2009; McGough et al., 2004) resulting in the activation of TrkB/ERK1/2 signaling (Jeanblanc et al., 2013; Logrip et al., 2009; McGough et al., 2004) , and in the induction of the dopamine D3 receptor (Jeanblanc et al., 2006) and preprodynorphin (Logrip et al., 2008) gene expression, which in turn keeps alcohol drinking in moderation. We further showed that dysregulation of the normal corticostriatal BDNF signaling drives the development and maintenance of rodents' heavy alcohol use Darcq et al., 2015; Logrip et al., 2009; Warnault et al., 2016) . For instance, we found that the development of excessive alcohol drinking is associated with increased contribution of p75NTR signaling in the DLS , and in lowered BDNF levels in the prefrontal cortex (PFC) of rodents (Darcq et al., 2015; Logrip et al., 2009) . In line with these findings, Tapocik et al. found that BDNF levels were reduced in rats that were made physically dependent on alcohol (Tapocik et al., 2014) . We, and Tapocik et al., further showed that the alcohol-dependent suppression of BDNF expression in the mPFC is mediated through the induction of miR30-5p (Darcq et al., 2015) , and miR206 (Tapocik et al., 2014) expression. In addition, alcohol-preferring rats display lower innate levels of BDNF in the bed nucleus of the stria terminialis (BNST) as well as in amygdalar regions as compared with alcohol non-preferring rats (Prakash et al., 2008; Raivio et al., 2014) . Dysregulation of BDNF signaling has also been associated with alcohol withdrawal-induced anxiety-like behaviors in rats (Pandey et al., 2006) .
Finally, we found that a single point mutation in the BDNF gene which produces a valine to methionine substitution results in compulsive heavy alcohol use despite negative consequences in mice . Interestingly, this single point mutation is also associated with an early onset of relapse in alcoholics undergoing treatment (Wojnar et al., 2009) , and with an increased likelihood to respond to alcohol cues in adolescents (Nees et al., 2015) . The Val66Met BDNF polymorphism can also predict the level of alcohol intake in alcohol-dependent patients when assessed together with polymorphisms for dopaminergic genes (Klimkiewicz et al., 2017) .
Together, these data suggest that BDNF is part of a homeostatic pathway that keeps alcohol intake in moderation, and that breakdown of this protective mechanism drives development and maintenance of AUD.
Similar to AUD, disruption of normal BDNF function has been associated with numerous of psychiatric disorders including depression, anxiety, stress and schizophrenia (Castren, 2014) .
Interestingly, a number of reports suggest that circuiting BDNF levels are inversely correlated with the severity of psychiatric disorders (Cattaneo et al., 2016) . Similarly, humans with AUD have reduced serum BDNF content compared to healthy controls (Heberlein et al., 2010; Nubukpo et al., 2017; Silva-Pena et al., 2019; Zanardini et al., 2011; Zhou et al., 2018) , which are still detected in abstinent alcoholics (Garcia-Marchena et al., 2017) . Lower BDNF content has also been correlated with greater reported alcohol withdrawal severity in alcoholics (Costa et al., 2011; Heberlein et al., 2010) . Finally, higher levels of BDNF was detected in alcoholics following 6 months of abstinence (Costa et al., 2011) suggesting that BDNF levels have been restored.
As disruption of normal BDNF signaling in the brain promotes the development of heavy alcohol use in rodents and possibly in humans (Ron and Berger, 2018) , and as lowered serum BDNF levels are associated with AUD, we set out to determine if the same is true for the BDNF machinery in the peripheral blood serum of rats. We further determined whether the decrease in BDNF serum content is associated with alterations in the levels of microRNAs targeting BDNF.
Methods

Reagents
BDNF E max ®ImmunoAssay System kit (cat. #G7610) was purchased from Promega (Madison, WI). BCA™ Protein Assay (cat. #23227) was purchased from Thermo Fisher Scientific (Waltham, MA). miRNeasy Serum/Plasma Kit (cat. #217184), miRCURY LNA RT kit (cat. #339340), and miRCury LNA SYBR Green master mix (cat. #339346) were purchased from Qiagen (Germantown, MD). Ethyl alcohol (190 proof) was purchased from VWR (Radnor, PA).
Animals
Male adult Long-Evans rats (~8-10 weeks of age) weighing approximately 250-300 grams were obtained from Harlan Labs. Animals were individually housed on paper-chip bedding (Teklad #7084), under a 12 hour light-dark cycle (lights on 0600 to 1800 h). Temperature and humidity were kept constant at 22 ± 2°C, and relative humidity was maintained at 50 ± 5%. Rats were allowed access to food (Teklad Global Diet #2918) and tap water ad libitum. All animal procedures were approved by the University of California, San Francisco Institutional Animal Care and Use Committee and were conducted in agreement with the Association for Assessment and Accreditation of Laboratory Animal Care (AAALAC, UCSF). Two independent cohorts were used for serum BDNF content and microRNA analysis. A third cohort of rats was used for platelet number analysis.
Preparation of alcohol solution
Alcohol solution was prepared from ethyl alcohol absolute anhydrous (190 proof) diluted 20% (v/v) in tap water.
Alcohol drinking paradigm
The intermittent-access to 20% alcohol two-bottle choice drinking procedure (IA20%-2BC) was conducted as previously described . Specifically, rats were given access to one bottle of 20% alcohol (v/v) in tap water and one bottle of water for 24 hours. Control mice had access to water only. Drinking sessions started at 12:00PM on Monday, Wednesday and Friday, with 24-or 48 hours (weekend) of alcohol-deprivation periods in which rats consumed only water.
The placement (left or right) of water or alcohol solution was alternated between each session to control for side preference. Water and alcohol bottles were weighed at the beginning and end of each alcohol drinking session. Rats were weighed once a week.
Serum blood collection
Rats were bled via the lateral tail vein before the initiation of the IA20%-2BC protocol and 24 hours after the final IA20%-2BC session ( Fig. 1A) . Animals were consistently bled in the morning.
Whole blood was kept for one hour at room temperature followed by centrifugation at 2000 x g for 10 minutes at 4°C. Room temperature incubation time was strictly monitored, as clotting can influence serum levels of BDNF (Maffioletti et al., 2014) . The resulting supernatant was aliquoted, snap frozen to minimize RNA degradation, and stored at -80°C for later ELISA and microRNAs expression analysis.
Enzyme-linked immunosorbent assay (ELISA)
ELISA assay was conducted according to manufacturer's instructions with minor modifications.
Specifically, 96-well plates were coated with 100 μl of monoclonal anti-BDNF antibody solution and incubated covered overnight at 4°C without shaking. Wells were washed once with TBST (20 mM Tris-HCl (pH 7.6), 150 mM NaCl, 0.05% Tween 20), then incubated with 200 μl of a Block & Sample buffer 1X for 1 hour at room temperature without shaking. Wells were washed once with TBST. Standard curves were prepared by diluting BDNF standards in Block & Sample buffer, with six serial 1:2 dilutions. A blank control was added for each plate. Samples were diluted in the same buffer (1:40) and added in triplicate. Plates were incubated for 4 hours at room temperature with shaking, and subsequently washed five times with TBST. One hundred μl of anti-BDNF polyclonal antibody solution was added and plates were incubated overnight at 4°C with shaking.
After five washes with TBST, 100 μl of secondary HRP conjugate antibody solution was added and plates were incubated for 1 hour at room temperature with shaking. Wells were washed five times with TBST. Subsequently, 100 μl of 3,3´,5,5´-tetramethylbenzidine (TMB) One Solution was added to each well, and plates were incubated for 30 minutes at room temperature. Reactions were stopped with 100 μl of 1M HCl, and absorbance at 450 nm was measured with an automated microplate reader within 30 minutes. Standard curves were plotted for each plate. Triplicates were averaged and values were corrected for total amount of protein in the sample as determined by BCA protein assay.
MicroRNA extraction and cDNA synthesis
MicroRNAs were extracted from the blood serum fraction using the miRNeasy Serum/Plasma Kit according to the manufacturer's instructions. RNA yield and purity were evaluated using a nanodrop ND-1000 spectrophotometer (ThermoFisher Scientific, Waltham, MA). cDNA synthesis was performed using the miRCURY LNA RT kit according to the manufacturer's instructions, starting with 150 ng of RNA and 5X reaction mix. Enzyme and nuclease-free water was added to a final volume of 20 μl. RNA spike-in of Unisp6 was added to each sample to monitor the efficiency of the reverse transcription reaction.
Real-time quantitative reverse transcriptase PCR (qRT-PCR)
qRT-PCR was performed using miRCURY LNA SYBR Green master mix according to the manufacturer's instructions, and experiments were run on an AB7900HT fast real-time PCR instrument (Applied Biosystems, Foster City, CA). Each data point represents an average of three replicates. Relative microRNA expression for each sample was determined by the following calculation; First, the average of cycle threshold (CT) of the miRNA of interest was subtracted from the CT of the control 5S rRNA to generate ΔCT. ΔCTs were then subtracted from the average of control ΔCT values for each sample to generate the ΔΔCT. Fold changes were then calculated
The following locked nucleic acid (LNA) PCR primers were used: miR30a-5p: 5′-UGUAAACAUCCUCGACUGGAAG-3', (Qiagen, cat. #YP00205695); miR195-5p: 5′-UAGCAGCACAGAAAUAUUGGC-3', (Qiagen, cat. #YP00205869); miR206-3p: 5'-UGGAAUGUAAGGAAGUGUGUGG-3', (Qiagen, cat. #YP00206073); miR191-5p: 5'-CAACGGAAUCCCAAAAGCAGCUG-3', (Qiagen, cat. #YP00204306); miR34c-5p: 5'-AGGCAGUGUAGUUAGCUGAUUGC-3', (Qiagen, cat. #YP00205659); Controls: 5S rRNA (Qiagen, cat. #YP00203906) and UniSp6 (Qiagen, cat. #YP00203954).
Platelet number analysis
Whole blood was collected from the tail artery directly into EDTA blood collection tubes (K2 EDTA 10.8 mg, BD Vacutainer) using a 25G needle (BD Vacutainer). An aliquot of 500 µl was used for complete blood count analysis. Platelet counts were determined using a Beckman Coulter Hematology Analyzer Ac·T 5diff AL (Beckman Coulter, Orange County, CA, USA).
Experimenters conducting the analysis were blind to the group assignment.
Statistical analyses
Statistical analyses were performed using SigmaStat 4.0 statistical software (San Jose, CA.).
Statistical significance was determined by using two-way ANOVA with repeated measures, Posthoc Student-Newman-Keus (SNK) test, and two-tailed t-test as indicated in the Figure Legends.
K-means clustering analysis was used as described in (Krahe et al., 2011) to determine the most parsimonious number of clusters for partitioning alcohol drinkers into behavior phenotypes based on the average alcohol intake (in g/kg) of the first four and last four drinking sessions. This was performed in an unsupervised manner by running K-means clustering on the data with different values of k ranging from 1 to 10, inclusive. The sum-of-squares error (SSE) for each value of k was calculated and the elbow criterion (James et al., 2013) was used to identify the corresponding k at which the asymptote plateaued (See Suppl. Fig. 1 for plot of number of clusters (k) vs SSE). K-means was then performed on the drinking data using the value of k determined with the aforementioned method. All clustering analyses were performed with Python v3.7 using the SciPy stack. Significance was set at p < 0.05.
Results
Animals that consume high levels of alcohol exhibited Late or Rapid Onset of heavy alcohol use
To investigate the association between serum BDNF and heavy alcohol use, we used Long-Evans rats as a model system and measured BDNF protein in blood serum prior to and at the end of an 8 week IA20%-2BC paradigm, a procedure that models episodic heavy alcohol drinking in humans (Carnicella et al., 2014 ) ( Figure 1A ).
We observed that out of the 54 rats used in the study, only 55.55 % of animals (n=30) were heavy drinkers consuming more than 3 g/kg/24 hours with an average of 4.27 +/-0.16 g/kg/24 hours at the last 4 sessions, which corresponds to blood alcohol concentration (BAC) of above 80 mg/dl or higher (Carnicella et al., 2014 ) ( Figure 1B ). This group of rats were used for the study.
Rats that consumed less than 1.5 g/kg/24 hours and an average of 0.97 +/-0.065 g/kg/24 hours were considered low drinkers and accounted for 24.07% of the animals (n=13). The remaining 20.37% of animals (n=11) were intermediate drinkers consuming alcohol more than 1.5 g/kg/24 hours but less than 3 g/kg/24 hours with an average of 2.34 +/-0.085 g/kg/24 hours ( Figure 1B) . Surprisingly, heavy alcohol users could be segregated into two distinct group; 70% of the animals (n=21) gradually escalated their alcohol use, drinking an average of 1.06 +/-0.152 g/kg/24 hours on week 1 vs. 4.23 +/-0.318 g/kg/24 hours on week 8 (Figure 2A-C, red) . These rats were defined as Late Onset animals. In contrast, 30% of the animals (n=9) consumed high levels of alcohol, even on the first session of drinking (Figure 2A In order to determine the number of clusters with an unsupervised approach, K-means clustering analysis (Krahe et al., 2011) was performed on the drinking data (the first four and last four drinking sessions). This approach confirmed the segregation of high drinkers in two groups ( Figure 2E ); One cluster of animals exhibited Rapid Onset of drinking ( Figure 2E , cluster 1, blue), and another cluster corresponded to Late Onset of drinking ( Figure 2E , cluster 2, red). Animals drinking on average below ~3.5g/kg over the first four and last four drinking sessions were clustered into a third group ( Figure 2E , cluster 3, green).
Together, these data indicate that rats exhibit two markedly different profiles of excessive drinking; rats whose alcohol intake gradually escalate, and animals that consume large quantities of alcohol at the initiation of the drinking paradigm.
Late onset and Rapid Onset heavy alcohol drinkers exhibit a decrease in serum BDNF
To measure BDNF content in the blood serum before and after a period of heavy alcohol use, we compared the basal levels of serum BDNF protein to the levels of the neurotrophic factor after 8 weeks (24-26 sessions) of IA20%-2BC ( Figure 1A ). We found that similar to the mPFC (Darcq et al., 2015; Tapocik et al., 2014) , heavy alcohol use reduces serum BDNF levels ( Figure   3A ). We then examined whether Late Onset and Rapid Onset rats exhibit a similar profile of BDNF quantity before and after excessive alcohol consumption. As shown in Figure 3B , the reduction in BDNF protein content was observed in both Rapid Onset and Late Onset rats. We next assessed whether the levels of serum BDNF are associated with other factors irrespective of the drinking phenotypes. To do so, we correlated serum BDNF levels with water consumption and found that 8 weeks of water intake had no effect on BDNF levels ( Figure 3C ). Together, these results show that a history of heavy alcohol use produces a reduction in serum BDNF content. Our data further suggests that low BDNF protein levels are detected after a history of heavy alcohol intake regardless of the rats' drinking profile.
microRNAs targeting BDNF are upregulated in the serum of Rapid Onset alcohol users
MicroRNAs have the capacity of targeting hundreds of mRNAs for degradation and/or translational repression (Qureshi and Mehler, 2012) . In addition, several microRNAs can target the same gene (Qureshi and Mehler, 2012) . Strikingly, BDNF is a target of numerous microRNAs including miR30a-5p (Darcq et al., 2015; Mellios et al., 2009; Mellios et al., 2008) , miR195 (Mellios et al., 2009; Mellios et al., 2008) , miR124 (Chandrasekar and Dreyer, 2009) , and miR206 (Tapocik et al., 2014) .
As BDNF expression is tightly regulated by numerous microRNAs, and as microRNAs are found in serum (Cortez and Calin, 2009 ), we measured the levels of miR30a-5p, miR195-5p, miR206-3p, and miR191-5p before and after IA20%2BC in Rapid Onset and Late Onset rats. We found that the basal level of the microRNAs is low in the serum of animals prior to alcohol exposure. As shown in Figure 4A ,C,E,G, IA20%2BC produced a significant increase in the level of all 4 tested microRNAs ranging from 2 fold increase (miR191-5p) to 20-fold increase (miR206-3p). Strikingly however, all 4 microRNAs were increased by alcohol only in the Rapid Onset animals but not in Late Onset animals ( Figure 4B,D,F,H) . We then measured the levels of miR134c-5p which is found in serum (Jin et al., 2018) but has not been associated with the regulation of BDNF expression. As shown in Figure 5 , there was no correlation between miR134-5p levels and alcohol intake. Together, these data suggest that microRNAs miR30a-5p, miR195-5p, miR206-3p, and miR191-5p known to target BDNF in the brain are robustly increased by alcohol in serum of Rapid Onset animals.
Platelet number is not altered by heavy alcohol use
Platelets represent the largest pool of BDNF in blood (Chacon-Fernandez et al., 2016) .
Secretion of BDNF by activated platelets is thus an important regulator of its bioavailability in serum (Fujimura et al., 2002) . Platelets are also a source of a large number of circulating microRNAs (Sunderland et al., 2017) . In humans, chronic alcoholism can cause thrombocytopenia, i.e. low platelet count (Eichner, 1973) . Thus, we determined whether the alterations in BDNF and miRs level in response to heavy alcohol use in rats could be due to a lower platelet number in the alcohol consuming rats. To do so, the platelet count was analyzed before and after 8 weeks of IA20%2BC. We found platelet counts to be unaffected by 8 weeks of heavy alcohol use, regardless of the rapidity of onset of heavy alcohol consumption ( Figure 6 ).
Discussion
Our study consists of three major findings: We report that IA20%2BC produces different profiles of heavy alcohol drinking. Specifically, we found that whereas the majority of rats gradually escalate their alcohol intake, a portion the animals consume large quantities of alcohol even at the initiation of the alcohol drinking regimen. We further show that serum BDNF levels are reduced in heavy alcohol drinking rats regardless of their alcohol drinking profile. We also report that alcohol increases the level of microRNAs targeting BDNF only in the serum of rats that exhibit Rapid Onset of drinking. Finally, we show that the alterations in BDNF levels as well as the expression of microRNAs targeting BDNF in response to excessive alcohol use are not due to changes in the number of platelets.
Rats exhibit Late Onset and Rapid Onset drinking profiles
AUD is characterized, in part, by excessive alcohol intake (Edwards et al., 2013; Enoch and Goldman, 2002) , and the IA20%2BC in rodents has been used as a reliable paradigm to probe for mechanisms that underlie the human disease (Carnicella et al., 2014) . Here, we report that this regimen does not produce homogenous levels of intake. We observed that only half of the rats consumed over 3g/kg/24 hours, an amount of alcohol that generates BAC of over 80mg% (Carnicella et al., 2014) . Surprisingly, we found that rats that drank high levels of alcohol can be further divided into two distinct groups: rats that start drinking low amounts of alcohol and escalate their alcohol drinking over a period of time (Late Onset), and rats with a very Rapid Onset of intake (Rapid Onset). This observation was detected in additional 4 cohorts of animals (data not shown), and was confirmed by an unsupervised K-means clustering analysis. It is plausible that the Late Onset and Rapid Onset animals have unique biological markups that underlie their drinking phenotypes. For example, it is possible that the genetic makeup of Long-Evans rats is not homogenous and that innate differences may be the root cause of the diverse drinking profiles.
Furthermore, genetic or epigenetic makeup of the Rapid Onset heavy drinkers may resemble the alcohol preferring rats (P rats), whereas the low drinkers resemble the alcohol non-preferring rats prefer alcohol over the highly rewarding substance, saccharine (Augier et al., 2018) . The authors further showed that the vulnerable rats also exhibited addiction-like phenotypes such as consuming alcohol despite adverse consequences (Augier et al., 2018) . Although this model has significant value, it is cumbersome and expensive to use. It is thus plausible that the Rapid Onset high drinking rats could be an easier model to study the addiction-prone population. Whether the Rapid Onset heavy alcohol users also exhibit other addiction-like phenotypes will be addressed in future studies. Regardless, differences in the drinking profiles of Long-Evans rats should be taken into consideration when investigating the neurobiological underpins of heavy alcohol use.
BDNF protein levels are dysregulated in Late Onset and Rapid Onset rats
In this study, we show that serum BDNF becomes dysregulated after 8 weeks of IA20%-2BC. The decrease in BDNF levels were detected in the serum of heavy drinkers regardless of whether or not they rapidly or slowly escalate their alcohol use. These results mirror previous findings that dysregulation of BDNF physiology is associated with AUD phenotypes in rodents (Darcq et al., 2015; Logrip et al., 2015; Logrip et al., 2009; Tapocik et al., 2014; Warnault et al., 2016) , as well as with the pathogenesis of AUD in humans (Ceballos and Sharma, 2016) . The potential use of BDNF as a biomarker of AUD is worthy of more detailed exploration.
A caveat of our study is the fact that we measured the levels of BDNF at only two time points, before and after 8 weeks of drinking. A careful time course is required to determine whether the escalation in alcohol drinking in the Late Onset animals parallels a gradual reduction in serum BDNF content. Interestingly, a meta-analysis in patients with major depression demonstrated that BDNF levels in the blood are restored in patients that responded to an anti-depressant medication, whereas BDNF blood concentration remained unchanged in non-responders (Polyakova et al., 2015) . These data suggest that BDNF in the blood is sensitive to a drug that targets the brain.
Whether or not BDNF in blood cells has a biological function and whether alterations in serum
BDNF levels by alcohol contribute to the disease are open questions. These questions are relevant not only to AUD, but also to other psychiatric disorders as serum BDNF is inversely correlated with depression (Molendijk et al., 2011) , bipolar disorder (Fernandes et al., 2011) , and schizophrenia (Rizos et al., 2008) .
Megakaryocytes, the progenitor cells and are a major source of BDNF in platelets (Chacon-Fernandez et al., 2016) . Specifically, megakaryocytes contain high levels of BDNF mRNA (Chacon-Fernandez et al., 2016) . The BDNF protein is stored in platelets in a-granules (Chacon-Fernandez et al., 2016), and is secreted into the plasma upon platelet activation (Fujimura et al., 2002) . Thus, it would be of interest to determine whether the BDNF production machinery in megakaryocytes and BDNF secretion mechanisms by platelets of Late Onset and Rapid Onset animals are altered by alcohol. BDNF is also expressed in T lymphocytes, B lymphocytes and monocytes (Linker et al., 2010; Linker et al., 2015) , as well as in endothelial cells (Nakahashi et al., 2000) (Kermani and Hempstead, 2019) . Future studies will determine whether alcohol alters BDNF's levels in one or all of these cell-types.
microRNAs targeting BDNF are upregulated only in Rapid Onset animals
We found that the levels of serum microRNAs targeting BDNF are relatively low in water consuming rats, however, miR30a-5p, miR195-5p, miR206-3p and miR191-5p expression were robustly upregulated by alcohol. In contrast, miR34c-5p, which does not target BDNF, was unaltered by alcohol. Strikingly, the increase in serum microRNAs was detected only in the Rapid Onset animals. This surprising result is yet another evidence that the Late Onset and Rapid Onset animals are genetically and/or epigenetically different.
Circulating microRNAs are transcribed in mononuclear blood cells, and packaged into exosomes which are released into the bloodstream and are internalized into recipient cells through an endocytosis process (Cortez and Calin, 2009 ). Serum microRNAs have been associated with numerous pathologic states (Cortez and Calin, 2009 ), including cancer (Mitchell et al., 2008) , autoimmune diseases (Jin et al., 2018) , as well as autism (Anitha and Thanseem, 2015) . A smallscale study also suggested that microRNA levels are altered in the serums of human subjects suffering from AUD (Ignacio et al., 2015) . It would be of interest to determine from which cell type the microRNAs are originating and through which mechanism alcohol produces a robust induction of their expression. It is likely that microRNAs target BDNF within the same cells however this possibility needs to be confirmed in future studies. Another remaining unanswered question is whether circulating microRNAs themselves have signaling properties, or are they merely a byproduct of cell homeostasis process.
Interestingly, the changes in miR30a-5p and miR206-3p in the serum of Rapid Onset rats is similar to the alterations detected in the mPFC of rodents (Darcq et al., 2015; Tapocik et al., 2014) . Recently, Torres-Berrio et. al. reported that miR218 in the blood of mice is produced in the mPFC (Torres-Berrio et al., 2019) . Thus, it is plausible that miRs targeting BDNF are produced in the mPFC transported by blood, where they can target BDNF mRNA in megakaryocytes, for example (Chacon-Fernandez et al., 2016) . Thus, if the periphery is a reflection of changes in the brain, then in addition of potentially serving as a diagnostic tool, serum microRNAs may serve as a promising toolbox to decipher alcohol's actions on the brain. Using bioinformatics tools, we identified several additional predicted targets of miR30a-5p, miR191-5p, miR195-5p and miR206-3p, all of which are expressed in the CNS (Table 1) . For example, miR30a-5p is predicted to target GSKIP, a GSK3-beta and PKA scaffolding protein (Dema et al., 2016) , and Rasd1, a member of the small G proteins, that plays a role in circadian rhythm (Cheng et al., 2006) . miR191-5p is predicted to target actin and microtubules binding proteins including tropomodulin 2 which has been associated with synaptic plasticity and memory (Cox et al., 2003; Omotade et al., 2018) . miR195-5p targets MAPK8, a member of the MAP kinase family (Davis, 2000) , and miR206-3p predicted targets include the actin binding protein, Coro1c (Roadcap et al., 2008) , and complexin 2, a SNARE machinery gene (Trimbuch and Rosenmund, 2016) . Thus, it would be of interest to explore the contribution of these targets and others to the Rapid Onset and/or the development of heavy alcohol use.
Intermittent access to 20% alcohol does not alter platelet number
Numerous reports indicate that chronic alcohol use reduces platelet count in human alcoholics (Mikhailidis et al., 1986; Renaud and Ruf, 1996; Rubin and Rand, 1994) . In contrast, we did not detect changes in platelet number in response to long-term alcohol use in rats. Taking into account that the BAC of rats drinking an average of 3-4 g/kg is in the range of 80 mg/dl, whereas the in vitro reduction in platelet number required concentrations of 200 mg/dl or higher (Mikhailidis et al., 1986; Rubin and Rand, 1994) , it is not surprising that alcohol did not alter platelet number in our model. In addition, in vitro studies suggest an inhibitory effect of alcohol on platelet aggregation (Mikhailidis et al., 1986; Rubin and Rand, 1994) . Whether or not cycles of binge and withdrawal alter platelet function, particularly platelet secretion mechanisms of relevance to BDNF, is an open question that will be addressed in future research.
Implications
In summary, we found that the drinking profiles in Long-Evans rats that were subjected to 8 weeks of IA20%2BC are not homogeneous. Only 55% of rats are heavy drinkers and a subset of heavy users exhibits a very Rapid Onset of drinking. We show that BDNF protein levels were reduced in Late Onset and Rapid Onset heavy drinkers, however, microRNAs targeting BDNF were found to be increased only in Rapid Onset animals. Thus, our data raise the possibility that BDNF targeting microRNAs may be developed as biomarkers for early detection of AUD.
microRNAs have been shown to be potential biomarkers for numerous diseases (Cortez and Calin, 2009 ) including depression (Yuan et al., 2018) . Thus, human research is warranted to determine whether serum microRNAs can be used as predictor of AUD, as well as tools to monitor the disease. Furthermore, intravenous administration of an inhibitor of microRNA miR122 reduced plasma cholesterol and fatty liver disease in mice (Cortez and Calin, 2009) , raising an interesting possibility that microRNA inhibitors could be developed as new therapy for the treatment of AUD. 
Figure legends
Figure 6 Heavy alcohol intake does not alter platelet count
Experimental design is depicted in Figure 1A . Animals were bled via tail artery one week before the initiation of the drinking paradigm (basal) TargetScan database (http://www.targetscan.org/mmu_72/) was used to identify mRNAs predicted to be targeted by microRNA families containing each of the serum microRNA sequences. Rat (rno) sequences were used for miR195-5p, miR206-3p and miR30a-5p. miR191-5p mouse (mmu) sequence was used as the rat sequence was unavailable in TargetScan. Gene candidates predicted to be targeted by the specific microRNAs are ordered according to the cumulative weighted context++ score (-1 to 1). A lower score indicates higher predicted repression of the mRNA by the microRNA, considering 14 features of both the microRNA and the putative mRNA target, in addition to the seed site complementarity .
Supplementary Figure 1 Number of clusters (k) vs SSE
Plot of number of clusters (k) vs. sum-of-squares error (SSE) for K-means clustering of alcohol intake (g/kg) averaged over the first four and last four drinking sessions (n=55). The decline in SSE plateauing at k=3 clusters supports the presence of three drinking phenotypes. Heavy alcohol intake does not alter platelet count Arhgap21 Rho GTPase activating protein 21 GTPase activating protein, cytoskeleton structure -0.40 Table 1 The TargetScanMouse database (http://www.targetscan.org/mmu_72/) was searched for genes predicted to be targeted by the miRNA family containing each of the rno-miRNAs elevated in the serum of rats with alcohol consumption -rno-miR-30a-5p, mmu-miR-191-5p, rno-miR-195-5p and rno-miR-206-3p (mouse was used in the case of miR-191-5p as rno-miR-191-5p was unavailable in TargetScan). Gene candidates predicted to be targeted by the specific miRNAs listed were isolated. Brain expression was determined by Allen Brain Atlas (https://mouse.brain-map.org/) or published literature. Brain-relevant predicted targets are ordered by cumulative weighted context++ score, which indicates the predicted repression of the mRNA by a single miRNA from multiple seed sites (Agarwal et al., 2015) .
